FDA’s Gottlieb says AI ‘holds enormous promise for the future of medicine’
The FDA is working to encourage the use of artificial intelligence (AI) technologies in healthcare, according the prepared remarks by the agency’s commissioner, Scott Gottlieb, MD, at Health Datapalooza in Washington, D.C.
“AI holds enormous promise for the future of medicine,” Gottlieb said in the remarks, as reported by CNBC. “We're actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies.”
Gottlieb added that the FDA expects the number of AI-based submissions to continue to rise, “starting with medical imaging devices,” as these technologies evolve.
Click below to read the full story from CNBC.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.